203 related articles for article (PubMed ID: 1859877)
1. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity.
Marie JP; Zittoun R; Sikic BI
Blood; 1991 Aug; 78(3):586-92. PubMed ID: 1859877
[TBL] [Abstract][Full Text] [Related]
2. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Herweijer H; Sonneveld P; Baas F; Nooter K
J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761
[TBL] [Abstract][Full Text] [Related]
3. MDR1 (multidrug resistance) gene expression in adult acute leukemia: correlations with blast phenotype.
Miyachi H; Takemura Y; Yonekura S; Komatsuda M; Nagao T; Arimori S; Ando Y
Int J Hematol; 1993 Jan; 57(1):31-7. PubMed ID: 8477061
[TBL] [Abstract][Full Text] [Related]
4. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques.
Brophy NA; Marie JP; Rojas VA; Warnke RA; McFall PJ; Smith SD; Sikic BI
Leukemia; 1994 Feb; 8(2):327-35. PubMed ID: 7905944
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
Hait WN; Choudhury S; Srimatkandada S; Murren JR
J Clin Invest; 1993 May; 91(5):2207-15. PubMed ID: 8098047
[TBL] [Abstract][Full Text] [Related]
6. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.
Anuchapreeda S; Thanarattanakorn P; Sittipreechacharn S; Tima S; Chanarat P; Limtrakul P
Arch Pharm Res; 2006 Oct; 29(10):866-73. PubMed ID: 17121181
[TBL] [Abstract][Full Text] [Related]
9. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
List AF; Spier C; Greer J; Wolff S; Hutter J; Dorr R; Salmon S; Futscher B; Baier M; Dalton W
J Clin Oncol; 1993 Sep; 11(9):1652-60. PubMed ID: 8102639
[TBL] [Abstract][Full Text] [Related]
11. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Leith CP; Kopecky KJ; Chen IM; Eijdems L; Slovak ML; McConnell TS; Head DR; Weick J; Grever MR; Appelbaum FR; Willman CL
Blood; 1999 Aug; 94(3):1086-99. PubMed ID: 10419902
[TBL] [Abstract][Full Text] [Related]
12. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.
Zhou DC; Marie JP; Suberville AM; Zittoun R
Leukemia; 1992 Sep; 6(9):879-85. PubMed ID: 1355575
[TBL] [Abstract][Full Text] [Related]
13. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
Gruber A; Areström I; Albertioni F; Björkholm M; Peterson C; Vitols S
Leuk Lymphoma; 1995 Aug; 18(5-6):435-42. PubMed ID: 8528050
[TBL] [Abstract][Full Text] [Related]
15. MDR1/P-GP expression as a prognostic factor in acute leukemias.
Marie JP; Legrand O
Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
[TBL] [Abstract][Full Text] [Related]
16. Expression of a multidrug resistance gene in human cancers.
Goldstein LJ; Galski H; Fojo A; Willingham M; Lai SL; Gazdar A; Pirker R; Green A; Crist W; Brodeur GM
J Natl Cancer Inst; 1989 Jan; 81(2):116-24. PubMed ID: 2562856
[TBL] [Abstract][Full Text] [Related]
17. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
Albertioni F; Gruber A; Areström I; Vitols S
Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
[TBL] [Abstract][Full Text] [Related]
19. A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples.
Illmer T; Schaich M; Oelschlägel U; Nowak R; Renner U; Ziegs B; Subat S; Neubauer A; Ehninger G
Leuk Res; 1999 Jul; 23(7):653-63. PubMed ID: 10400187
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
Leith CP; Kopecky KJ; Godwin J; McConnell T; Slovak ML; Chen IM; Head DR; Appelbaum FR; Willman CL
Blood; 1997 May; 89(9):3323-9. PubMed ID: 9129038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
